These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3562490)

  • 1. Vinpocetine enhances retrieval of a step-through passive avoidance response in rats.
    DeNoble VJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):183-6. PubMed ID: 3562490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.
    DeNoble VJ; Repetti SJ; Gelpke LW; Wood LM; Keim KL
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1123-8. PubMed ID: 3714768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats.
    Okuyama S; Hashimoto-Kitsukawa S; Ogawa S; Imagawa Y; Kawashima K; Kawashima Y; Araki H; Otomo S
    Gen Pharmacol; 1994 Nov; 25(7):1311-20. PubMed ID: 7896040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
    Cumin R; Bandle EF; Gamzu E; Haefely WE
    Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.
    Nyakas C; Felszeghy K; Szabó R; Keijser JN; Luiten PG; Szombathelyi Z; Tihanyi K
    CNS Neurosci Ther; 2009; 15(2):89-99. PubMed ID: 19492990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
    Deshmukh R; Sharma V; Mehan S; Sharma N; Bedi KL
    Eur J Pharmacol; 2009 Oct; 620(1-3):49-56. PubMed ID: 19699735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemically administered N-methyl-D-aspartate interferes with acquisition of a passive avoidance response in rats.
    Jones KW; Schaeffer CL; DeNoble VJ
    Pharmacol Biochem Behav; 1989 Sep; 34(1):181-5. PubMed ID: 2696984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydergine enhances memory in mice.
    Flood JF; Smith GE; Cherkin A
    J Pharmacol; 1985; 16 Suppl 3():39-49. PubMed ID: 4094446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanism of haloperidol-induced enhancement of memory retrieval.
    Chugh Y; Saha N; Sankaranarayanan A; Sharma PL
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):161-4. PubMed ID: 2051840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of lindane, DDT, and chlordecone on avoidance responding and seizure activity.
    Tilson HA; Shaw S; McLamb RL
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):57-65. PubMed ID: 2436354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nootropic drugs on the memory-impairing effect of diethyldithiocarbamate and clonidine in "step down" passive avoidance in albino rats.
    Genkova-Papasova M; Lazarova-Bakurova M
    Acta Physiol Pharmacol Bulg; 1988; 14(4):36-41. PubMed ID: 2854355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a new anxiolytic, DN-2327, on learning and memory in rats.
    Wada T; Fukuda N
    Pharmacol Biochem Behav; 1992 Mar; 41(3):573-9. PubMed ID: 1350101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rutin on a passive avoidance test in rats.
    Nassiri-Asl M; Zamansoltani F; Javadi A; Ganjvar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):204-7. PubMed ID: 19914327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice.
    King GA
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):299-307. PubMed ID: 3592869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of BY-1949 on three kinds of experimental amnesia in rodents].
    Tanabe S; Ikeda Y; Sugawa M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):297-305. PubMed ID: 2251878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
    Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
    Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
    Miskolczi P; Kozma K; Polgár M; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vinburnine on experimental models of learning and memory impairments.
    Drago F; Grassi M; Valerio C; Spadaro F; D'Agata V; Lauria N
    Pharmacol Biochem Behav; 1990 Sep; 37(1):53-7. PubMed ID: 2263666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.